Outcomes in Stable Patients With Previous Atherothrombotic Events Receiving Vorapaxar Who Experience a New Acute Coronary Event (from TRA2°P-TIMI 50) by Berg, David D., MD, Bonaca, Marc P., MD, MPH, Braunwald, Eugene, MD, Corbalan, Ramon, MD, Goto, Shinya, MD, PhD, Kiss, Robert G., MD, PhD, Murphy, Sabina A., MPH, Scirica, Benjamin M., MD, MPH, Spinar, Jindrich, MD, Morrow, David A., MD, MPH

Get full text

Very late drug-eluting stent thrombosis after nonsteroidal anti-inflammatory drug treatment despite dual antiplatelet therapy by Merkely, Bela, MD PhD DSc, Toth-Zsamboki, Emese, MD PhD, Becker, David, MD, Beres, Bernat Janos, MD, Szabó, György, MD, Vargova, Katarina, MD, Fülöp, Gabor, MD, Kerecsen, Gabor, MD, Preda, Istvan, MD PhD DSc, Spaulding, Christian, MD, Kiss, Robert G., MD PhD

Get full text

Defining age-related differences in outcome after traumatic spinal cord injury: analysis of a combined, multicenter dataset by Wilson, Jefferson R., MD, PhD, Davis, Aileen M., PhD, Kulkarni, Abhaya V., MD, PhD, Kiss, Alex, PhD, Frankowski, Ralph F., PhD, Grossman, Robert G., MD, Fehlings, Michael G., MD, PhD

Get full text

Otamixaban for the treatment of patients with non-ST-elevation acute coronary syndromes (SEPIA-ACS1 TIMI 42): a randomised, double-blind, active-controlled, phase 2 trial by Sabatine, Marc S, Dr, Antman, Elliott M, Prof, Widimsky, Petr, Prof, Ebrahim, Iftikhar O, MBBCh, Kiss, Robert G, MD, Saaiman, André, MD, Polasek, Rostislav, MD, Contant, Charles F, PhD, McCabe, Carolyn H, BS, Braunwald, Eugene, Prof

Get full text